Skip to main content
An official website of the United States government

monoclonal antibody HuAFP31

A humanized monoclonal antibody directed against alpha fetoprotein with potential antineoplastic activity. Upon administration, monoclonal antibody HuAFP31 (mAb HuAFP31) binds to and stimulates a cytotoxic T lymphocyte (CTL) response against tumor cells that express alpha fetoprotein.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Abbreviation:MOAB HuAFP31
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search